Published in Ann N Y Acad Sci on May 31, 1994
An assessment of the antisense properties of RNase H-competent and steric-blocking oligomers. Nucleic Acids Res (1995) 1.21
Synthesis of 3H-labeled nucleoside-methyl[CT3]phosphonamidite and incorporation into methylphosphonate oligonucleotides for biodistribution and biostability studies. Nucleic Acids Res (1995) 0.77
Use of ribozymes and antisense oligodeoxynucleotides to investigate mechanisms of drug resistance. Cytotechnology (1998) 0.75
New modalities in oncology: antisense oligonucleotides. Proc (Bayl Univ Med Cent) (2002) 0.75
Ribozyme therapy: RNA enzymes to the rescue. Yale J Biol Med (2003) 0.75
Sensitivity of Pseudomonas aeruginosa to antibiotics: emergence of strains highly resistant to carbenicillin. Lancet (1969) 8.94
Synthesis of DNA via deoxynucleoside H-phosphonate intermediates. Nucleic Acids Res (1986) 4.24
Dialkylformamidines: depurination resistant N6-protecting group for deoxyadenosine. Nucleic Acids Res (1983) 3.62
Prophylaxis and therapy for Pseudomonas aeruginosa infection with carbenicillin and with gentamicin. Br Med J (1967) 3.15
Transfer of anibioic resistanceetween Pseudomonas aeruginosa, Escherichia coli, and other gram-negative bacilli in rns. Lancet (1971) 3.05
Inhibition of apoptosis during development of colorectal cancer. Cancer Res (1995) 2.77
Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using posttransplantation cyclophosphamide. Biol Blood Marrow Transplant (2002) 2.69
Antisense gene inhibition by oligonucleotides containing C-5 propyne pyrimidines. Science (1993) 2.56
Durable treatment-free remission after high-dose cyclophosphamide therapy for previously untreated severe aplastic anemia. Ann Intern Med (2001) 2.47
Biological and immunochemical properties of culture filtrates of virulent and avirulent strains of Pseudomonas aeruginosa. Br J Exp Pathol (1968) 2.47
Kernel abortion in maize : I. Carbohydrate concentration patterns and Acid invertase activity of maize kernels induced to abort in vitro. Plant Physiol (1986) 2.36
New chemical methods for synthesizing polynucleotides. Nucleic Acids Symp Ser (1980) 2.32
Current concepts in antisense drug design. J Med Chem (1993) 2.28
Triple helix formation inhibits transcription elongation in vitro. Proc Natl Acad Sci U S A (1991) 2.28
Antiserum and antibiotic in the prophylaxis of burns against Pseudomonas aeruginosa. Br J Plast Surg (1966) 2.21
Nucleosides with a twist. Can fixed forms of sugar ring pucker influence biological activity in nucleosides and oligonucleotides? J Med Chem (1996) 2.08
Inoculum-dependent division lag of Bacillus cultures and its relation to an endogenous factor(s) ("schizokinen"). J Bacteriol (1966) 2.07
Microtubule changes and cytotoxicity in leukemic cell lines treated with taxol. Cancer Res (1988) 1.99
Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia. Blood (1994) 1.91
The role of the O and K antigens in determining the resistance of Klebsiella aerogenes to serum killing and phagocytosis. J Gen Microbiol (1983) 1.81
Potent and selective inhibition of gene expression by an antisense heptanucleotide. Nat Biotechnol (1996) 1.74
A synchronization effect and its application to stuttering by a portable apparatus. J Appl Behav Anal (1968) 1.74
Quantitative analysis of bone marrow CD34 cells in aplastic anemia and hypoplastic myelodysplastic syndromes. Leukemia (2006) 1.74
Decreased erythropoietin response in patients with the anemia of cancer. N Engl J Med (1990) 1.72
Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following bone marrow transplantation. J Clin Oncol (1995) 1.71
In Vitro Sugar Transport in Zea mays L. Kernels : I. Characteristics of Sugar Absorption and Metabolism by Developing Maize Endosperm. Plant Physiol (1987) 1.70
Hybridization triggered cross-linking of deoxyoligonucleotides. Nucleic Acids Res (1986) 1.69
Targeted random mutagenesis: the use of ambiguously synthesized oligonucleotides to mutagenize sequences immediately 5' of an ATG initiation codon. Nucleic Acids Res (1983) 1.60
Pharmacokinetics of busulfan: correlation with veno-occlusive disease in patients undergoing bone marrow transplantation. Cancer Chemother Pharmacol (1989) 1.57
Passive protective properties of serum fractions from mice inoculated with an anti-pseudomonas vaccine. Immunology (1972) 1.56
Chemical synthesis and biological studies on mutated gene-control regions. Cold Spring Harb Symp Quant Biol (1983) 1.55
A new polyvalent Pseudomonas vaccine. J Med Microbiol (1977) 1.51
Immunoablative high-dose cyclophosphamide without stem-cell rescue for refractory, severe autoimmune disease. Ann Intern Med (1998) 1.51
Phase I trial of interferon gamma to potentiate cyclosporine-induced graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancer. J Clin Oncol (1994) 1.50
An anti-parallel triple helix motif with oligodeoxynucleotides containing 2'-deoxyguanosine and 7-deaza-2'-deoxyxanthosine. Nucleic Acids Res (1993) 1.47
Reduced intensity HLA-haploidentical BMT with post transplantation cyclophosphamide in nonmalignant hematologic diseases. Bone Marrow Transplant (2008) 1.45
Absorbability of beta-sitosterol in humans. Metabolism (1969) 1.44
Early protection by vaccines in burns. Br J Exp Pathol (1971) 1.44
Oligonucleotide-mediated triple helix formation using an N3-protonated deoxycytidine analog exhibiting pH-independent binding within the physiological range. Proc Natl Acad Sci U S A (1992) 1.44
Polyomavirus BK infection in blood and marrow transplant recipients. Bone Marrow Transplant (2007) 1.41
A serum-resistant cytofectin for cellular delivery of antisense oligodeoxynucleotides and plasmid DNA. Proc Natl Acad Sci U S A (1996) 1.38
Successful transfer of DHP-degrading bacteria from Hawaiian goats to Australian ruminants to overcome the toxicity of Leucaena. Aust Vet J (1986) 1.36
Selective radiosensitization of p53-deficient cells by caffeine-mediated activation of p34cdc2 kinase. Nat Med (1996) 1.35
Tropical legumes of the genus Stylosanthes immobilize and kill cattle ticks. Nature (1982) 1.35
Specificity of early protective responses induced by pseudomonas vaccines. J Hyg (Lond) (1972) 1.31
The role of polymorphonuclear leucocytes in protecting mice vaccinated against Pseudomon as aeruginosa infections. Br J Exp Pathol (1973) 1.31
The invasion of burned skin by Pseudomonas aeruginosa. Br J Dermatol (1973) 1.31
BCR-ABL-mediated inhibition of apoptosis with delay of G2/M transition after DNA damage: a mechanism of resistance to multiple anticancer agents. Blood (1995) 1.30
Multilineage glycosylphosphatidylinositol anchor-deficient haematopoiesis in untreated aplastic anaemia. Br J Haematol (2001) 1.29
Controlled trials of a polyvalent pseudomonas vaccine in burns. Lancet (1979) 1.28
Cardiovascular and risk factor evaluation of healthy American adults. A statement for physicians by an Ad Hoc Committee appointed by the Steering Committee, American Heart Association. Circulation (1987) 1.27
Pancreatic lymphoma. Is surgery mandatory for diagnosis or treatment? Ann Surg (1989) 1.27
Pharmacokinetics and metabolism of selected prodrugs of PMEA in rats. Drug Metab Dispos (1997) 1.26
CT of lymphoma: spectrum of disease. Radiographics (1991) 1.26
Resistance of paroxysmal nocturnal hemoglobinuria cells to the glycosylphosphatidylinositol-binding toxin aerolysin. Blood (1999) 1.24
BCR-ABL gene rearrangement and expression of primitive hematopoietic progenitors in chronic myeloid leukemia. Blood (1993) 1.23
Protection against Pseudomonas aeruginosa infection by immunisation with fractions of culture filtrates of Ps. aeruginosa. Br J Exp Pathol (1968) 1.21
Low mortality in burned patients in a Pseudomonas vaccine trial. Lancet (1978) 1.21
Controlled trial of Pseudomonas immunoglobulin and vaccine in burn patients. Lancet (1980) 1.21
A new Pseudomonas vaccine: preliminary trial on human volunteers. J Hyg (Lond) (1976) 1.21
A prospective pharmacologic evaluation of age-related toxicity of adjuvant chemotherapy in women with breast cancer. Cancer Invest (2000) 1.20
Long-term results of blood and marrow transplantation for Hodgkin's lymphoma. J Clin Oncol (2001) 1.20
Geographic differences in vertical connectivity in the Caribbean coral Montastraea cavernosa despite high levels of horizontal connectivity at shallow depths. Mol Ecol (2014) 1.20
Passive immunisation against Gram-negative bacilli in burns. Br J Exp Pathol (1970) 1.18
Site and mechanism of antisense inhibition by C-5 propyne oligonucleotides. Biochemistry (1995) 1.18
Protein engineering thrombin for optimal specificity and potency of anticoagulant activity in vivo. Biochemistry (1996) 1.17
Migraine: a platelet disorder. Lancet (1981) 1.16
Complete remission in severe aplastic anemia after high-dose cyclophosphamide without bone marrow transplantation. Blood (1996) 1.16
Protective properties and haemagglutinins in serum from humans and in serum from mice injected with a new polyvalent Pseudomonas vaccine. Br J Exp Pathol (1975) 1.14
Topoisomerase II levels and drug sensitivity in adult acute myelogenous leukemia. Blood (1994) 1.14
High frequencies of leukemia stem cells in poor-outcome childhood precursor-B acute lymphoblastic leukemias. Leukemia (2010) 1.13
The role of recumbency in the prevention and treatment of postspinal headache. Anesth Analg (1974) 1.13
Resistance to apoptosis caused by PIG-A gene mutations in paroxysmal nocturnal hemoglobinuria. Proc Natl Acad Sci U S A (1997) 1.10
Transmission of a T-cell lymphoma by allogeneic bone marrow transplantation. N Engl J Med (2001) 1.10
Passive protection of mice against Pseudomonas aeruginosa by serum from recently vaccinated mice. Br J Exp Pathol (1971) 1.10
Kernel Abortion in Maize : II. Distribution of C among Kernel Carbohydrates. Plant Physiol (1986) 1.10
Acute bleeding after bone marrow transplantation (BMT)- incidence and effect on survival. A quantitative analysis in 1,402 patients. Blood (1998) 1.09
Allogeneic bone marrow transplantation, zidovudine, and human immunodeficiency virus type 1 (HIV-1) infection. Studies in a patient with non-Hodgkin lymphoma. Ann Intern Med (1989) 1.08
Standard depth burns in the rat: the importance of the hair growth cycle. Br J Plast Surg (1967) 1.06
Oestrogen-regulated genes in breast cancer: association of pLIV1 with lymph node involvement. Eur J Cancer (1994) 1.06
Effects of topical chemoprophylaxis on transferable antibiotic resistance in burns. Lancet (1972) 1.05
Phase I and pharmacodynamic study of the topoisomerase I-inhibitor topotecan in patients with refractory acute leukemia. J Clin Oncol (1994) 1.04
Triplex formation by oligonucleotides containing 5-(1-propynyl)-2'-deoxyuridine: decreased magnesium dependence and improved intracellular gene targeting. Biochemistry (1999) 1.04
In Vitro Sugar Transport in Zea mays L. Kernels : II. Characteristics of Sugar Absorption and Metabolism by Isolated Developing Embryos. Plant Physiol (1987) 1.03
Intracellular killing of different strains of Pseudomonas aeruginosa by human leucocytes. Br J Exp Pathol (1974) 1.01
Mortality of joggers. JAMA (1982) 1.01
Inhibition of human immunodeficiency virus type-1 env expression by C-5 propyne oligonucleotides specific for Rev-response element stem-loop V. Biochemistry (1994) 1.01
Oligodeoxynucleotides containing C-7 propyne analogs of 7-deaza-2'-deoxyguanosine and 7-deaza-2'-deoxyadenosine. Nucleic Acids Res (1996) 1.00
Dynamics of maize endosperm development and DNA endoreduplication. Proc Natl Acad Sci U S A (1995) 1.00
A cytosine analog that confers enhanced potency to antisense oligonucleotides. Proc Natl Acad Sci U S A (1999) 1.00
Treatment of acute herpes zoster using ultrasonic therapy. Report on a series of twelve patients. Physiotherapy (1984) 1.00